Mounjaro has been associated with gastrointestinal adverse reactions, which incorporate nausea, vomiting, and diarrhea. These functions may possibly lead to dehydration, which if severe could cause acute kidney injury. In people treated with GLP-1 receptor agonists, there have been postmarketing reports of acute kidney personal injury and worsening